Skip to main content
Clinical Trials/ITMCTR1900002845
ITMCTR1900002845
Completed
Phase 1

Study for safety and efficacy of fasting therapy of metabolic syndrome

Sichuan Hospital of Integrated Chinese and Western Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Sichuan Hospital of Integrated Chinese and Western Medicine
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational study
Sex
All

Investigators

Sponsor
Sichuan Hospital of Integrated Chinese and Western Medicine

Eligibility Criteria

Inclusion Criteria

  • Meet the Global consensus on Metabolic Syndrome of the International Diabetes Alliance, abdominal obesity (waist circumference \>\=90cm for men and \>\=80cm for women);
  • 1\. HDL\-c (high\-density lipoprotein cholesterol) \<0\.9mmol/L (male) or 1\.1mmol/L (female);
  • 2\. TG (triglyceride) \>1\.7mmol/L;
  • 3\. SBP (systolic blood pressure) \>\=130mmHg, or DBP (diastolic blood pressure) \>\=85mmHg;
  • 4\. FPG (fasting blood glucose) 5\.6 to 11\.1 mmol/L;
  • 5\. 9\.0% or greater HbA1C; Participants are informed of this study and volunteered to participate in the study.

Exclusion Criteria

  • 1\. type 1 DM or special type DM, or GDM; Serious complications of liver, kidney, brain, heart and other important organs and systems;
  • 2\. participants with other drug trials within the past 3 months; Antibiotics and microecological preparations were taken within 4 weeks;
  • 3\. poor blood glucose control and insulin injection \>\=30u;
  • 4\. secondary hypertension;
  • 5\. age \<18 years and \>\=70 years;
  • 6\. associated with protein\-wasting diseases;
  • 7\. diarrhea or other gastrointestinal diseases within the last 4 weeks; Previous history of gastrointestinal surgery.

Outcomes

Primary Outcomes

Not specified

Similar Trials